Mechanisms of hepatic fibrogenesis.

By S. Friedman. Gastroenterology, 2008

1,575 citations recorded by the source corpus.

Subfields: Epidemiology, Genetics, Hepatology

View Paper: https://www.semanticscholar.org/paper/d5b5fc3421db05aadd14f3593ef4d82bd40cf778

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. Natascha Roehlen
2. E. Crouchet
3. T. Baumert

In Genetics

1. Natascha Roehlen
2. E. Crouchet
3. T. Baumert

In Hepatology

1. Natascha Roehlen
2. E. Crouchet
3. T. Baumert

Citations in the corpus

• Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives (2020, background): “In addition, activated cells express high levels of alpha Smooth Muscle Actin (α-SMA) and Tissue Inhibitor of Metalloproteinase 1 (TIMP1) which contribute to the changes from a adipocytic phenotype to a pro-fibrogenic and inflammatory phenotype [54,55].”
• TGF-β/SMAD Pathway and Its Regulation in Hepatic Fibrosis (2016, background): “In patients with HF, increased concentrations of TGF-β1 correlate with the severity of hepatic fibrosis, suggesting a link between TGF-β expression and progressive liver disease (Friedman 2008; Gressner and Weiskirchen 2006; Lee and Friedman 2011).”
• Kupffer Cells in the Liver (2013, neutral): “While MMPs can actually contribute to fibrosis during the progression stage, they can also promote the removal of extracellular matrix during the resolution of fibrosis (30).”